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Values are mean ± SD. Sensory block level was expressed as median 
value. Group M: meperidine group, Group N: nafopam group. ASA: 
American Society of Anesthesiologists physical status.





Shivering score (n, 0/1/2/3)
Nausea (n)
Respiratory depression (n)















Values are number of patients (%). Group M: meperidine group, 
Group N: nefopam group. *P < 0.05, compared to Group M.
Fig. 1. Change of hemodynamics and body temperature. (A) mean 
arterial pressure, (B) heart rate, and (C) tympanic membrane tem pe-
rature. Group M: meperidine group, Group N: nafopam group. *P < 0.05, 
compared to Group M at the same times. †P < 0.05, compared to the 
baseline value of the same group.
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